Literature DB >> 9659222

Multiple signals regulate the intracellular trafficking of HLA-DM in B-lymphoblastoid cells.

J Copier1, P Potter, S H Sacks, A P Kelly.   

Abstract

Peptide loading by major histocompatibility complex (MHC) class II molecules occurs in the endocytic pathway and is critically dependent upon the function of the class II-related molecule human leucocyte antigen-DM (HLA-DM). We have previously shown that a tyrosine-based lysosomal targeting signal present in the cytoplasmic tail of DMB has the capacity to target HLA-DM to peptide-loading compartments in HeLa cells. Here we investigate the importance of this signal in directing HLA-DM to processing compartments in professional antigen-presenting cells. We reconstituted a DMB-negative B-lymphoblastoid cell line with native or targeting-deficient DMB and show that in the absence of its tyrosine signal, DMB-Y230A is as efficient as the wild-type molecule in inducing MHC class II SDS stable dimer formation; restoring expression of the conformation-dependent DR3 epitope 16:23; the removal of CLIP; and accessing lysosomal peptide-loading compartments. By transient transfection in HeLa cells we show that Ii is able to compensate for loss of DMB-encoded targeting information. These data imply that in cells expressing physiological levels of class II, Ii and DM, there is sufficient association with Ii to direct the majority of DM into the endocytic pathway. Thus MHC class II and HLA-DM may follow similar intracellular trafficking pathways on route to antigen-processing compartments.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9659222      PMCID: PMC1364128          DOI: 10.1046/j.1365-2567.1998.00461.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  The antigen-processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation.

Authors:  J M Riberdy; P Cresswell
Journal:  J Immunol       Date:  1992-04-15       Impact factor: 5.422

2.  HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides.

Authors:  J M Riberdy; J R Newcomb; M J Surman; J A Barbosa; P Cresswell
Journal:  Nature       Date:  1992-12-03       Impact factor: 49.962

3.  Intracellular transport of class II MHC molecules directed by invariant chain.

Authors:  V Lotteau; L Teyton; A Peleraux; T Nilsson; L Karlsson; S L Schmid; V Quaranta; P A Peterson
Journal:  Nature       Date:  1990-12-13       Impact factor: 49.962

4.  MHC class II-associated invariant chain contains a sorting signal for endosomal compartments.

Authors:  O Bakke; B Dobberstein
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

5.  Isolation and characterization of HL-A variants in cultured human lymphoid cells.

Authors:  D Pious; P Hawley; G Forrest
Journal:  Proc Natl Acad Sci U S A       Date:  1973-05       Impact factor: 11.205

6.  HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells.

Authors:  S P Fling; B Arp; D Pious
Journal:  Nature       Date:  1994-04-07       Impact factor: 49.962

7.  An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules.

Authors:  P Morris; J Shaman; M Attaya; M Amaya; S Goodman; C Bergman; J J Monaco; E Mellins
Journal:  Nature       Date:  1994-04-07       Impact factor: 49.962

8.  Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments.

Authors:  F Sanderson; M J Kleijmeer; A Kelly; D Verwoerd; A Tulp; J J Neefjes; H J Geuze; J Trowsdale
Journal:  Science       Date:  1994-12-02       Impact factor: 47.728

9.  Editing of the HLA-DR-peptide repertoire by HLA-DM.

Authors:  H Kropshofer; A B Vogt; G Moldenhauer; J Hammer; J S Blum; G J Hämmerling
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

10.  Direct demonstration of an HLA-DR allotypic determinant on the low molecular weight (beta) subunit using a mouse monoclonal antibody specific for DR3.

Authors:  J P Johnson; T Meo; G Riethmüller; D J Schendel; R Wank
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.